Eagle Pharmaceuticals, Inc.
EGRXDelisted Nov 26, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000827871
Eagle Pharmaceuticals, Inc. was delisted on Nov 26, 2024; its insiders filed their last Form 4 on Mar 1, 2024; 65 institutions reported holding it in 13F filings for Q3 2024, worth $31.9M in total; no superinvestor held it.
Q3 2025 vs. Q2 2025
How the institutions holding Eagle Pharmaceuticals, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 2 | 2 | 0 |
| Shares | 12.3K | 12.3K | 0 (0.0%) |
| Value | $35.8K | $33.3K | −$2.47K (−6.9%) |
New holders (0)
Institutions that held Eagle Pharmaceuticals, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
None.
Sold out (0)
Institutions that held Eagle Pharmaceuticals, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
None.